Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Cisplatin 31Fluorouracil 24Paclitaxel 19Radiotherapy 15Docetaxel 11Esophagectomy 8Radiation 7Neoadjuvant Therapy 7Carboplatin 7Irinotecan 6Oxaliplatin 5Leucovorin 5Capecitabine 5sintilimab 4pembrolizumab 4camrelizumab 4TP protocol 4Surgical Procedures, Operative 4Drug Therapy 4Chemotherapy, Adjuvant 4Trastuzumab 3Immunotherapy 3Epirubicin 3Chemoradiotherapy 3tislelizumab 2nimotuzumab 2S 1 (combination) 2Radiotherapy, Adjuvant 2Platinum Compounds 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Esophageal Neoplasms × Patient Reported Outcome Measures × Clear all
NCT07211009 2025-10-07

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

Sichuan University

Phase 3 Not yet recruiting
240 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡